Equities

Immuneering Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
IMRX:NMQ

Immuneering Corp

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (USD)4.96
  • Today's Change-0.09 / -1.78%
  • Shares traded479.66k
  • 1 Year change+172.53%
  • Beta0.4542
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Key statistics

On Thursday, Immuneering Corp (IMRX:NMQ) closed at 4.96, 350.91% above the 52 week low of 1.10 set on May 12, 2025.
52-week range
Today
1.10May 12 202510.08Sep 22 2025
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open5.04
High5.15
Low4.90
Bid4.80
Offer5.10
Previous close5.05
Average volume1.02m
Shares outstanding64.57m
Free float53.04m
P/E (TTM)--
Market cap326.08m USD
EPS (TTM)-1.78
USD
Data delayed at least 15 minutes, as of Feb 12 2026 21:00 GMT.
More ▼
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.